| |||||||||||||
TCPIAIA 2024 : Targeted Chemotherapy with Personalized Immunotherapy: An AI Approach | |||||||||||||
Link: http://drbpl.com/news.html | |||||||||||||
| |||||||||||||
Call For Papers | |||||||||||||
Researchers are working hard to develop methods that will aid in deciding which therapies are the most successful since they have discovered that, for certain patients, the best results may be reached by combining precisely targeted chemotherapy with personalized immunotherapy. As a result of this discovery, researchers are attempting to devise strategies that will assist in establishing which treatments are the most effective. When lung cancer is detected at an early stage, patients who are candidates for surgery alone have a cure rate that ranges between sixty and seventy percent. Researchers are attempting to improve the percentage of patients who are cured by surgical procedures by combining them with other treatment modalities.
Following surgical intervention, patients are now eligible to pursue immunotherapy as well as treatment targeted at the specific cancer. These medications work to aid the body in destroying any cancer cells that may still be present after treatment. Others may benefit from a combination of chemotherapy and immunotherapy, which may help reduce the size of a tumor and make it possible for patients to undertake more sophisticated surgical procedures without as much risk. In the years to come, treatment for cancer will focus on. There have been significant leaps forward in terms of the treatment of cancer over the course of the last 20 years. We now have a far better understanding of how our cells interact with one another, how cancer suppresses and hides from the immune system, and how to support the body in reacting to stop the spread of cancer; nevertheless, there is still a great deal more to learn in this field. Instead of treating patients with medications that are detrimental to the body as a whole, researchers are now aiming to identify the molecules that play an essential part in the communication that takes place between cells. This study, if it proves fruitful, might help pave the way for the development of novel immunotherapies that provide the body with assistance in its fight against cancer. In order to accurately plan cancer treatment, participation from a number of different members of the healthcare team is essential. Our cancer experts are able to determine the most effective treatment timeline and approach when they work together to uncover mutations that can be targeted with immunotherapy and discover mutations that can be targeted with immunotherapy. Editors: Prasanalakshmi Balaji College of Computer Science, King Khalid University, Abha, Kingdom of Saudi Arabia. Dr.Abhishek Kumar Department of CSE, Chandigarh University, Punjab, India. Dr.Prasenjit Das Department of CSE, Chandigarh University, Punjab, India. Mr.Chetan Sharma UpGrad Campus Bengaluru, India. Dr.Jade H.Y.Chen Zhejiang University, China. |
|